1. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study;Fisher;J Natl Cancer Inst,1998
2. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes;Vogel;JAMA,2006
3. Continued breast cancer risk reduction in post-menopausal women treated with raloxifene: 4-year results from the MORE trial;Cauley;Breast Cancer Res Treat,2001
4. National Cancer Institute. Cancer.Gov. FDA approval for raloxifene hydrochloride. Available at: https://www.cancer.gov/about-cancer/treatment/drugs/fda-raloxifene-hydrochloride. Accessed: October 2, 2017.
5. US Department of Health and Human Services, HHS News. Tamoxifen approved for reducing breast cancer incidence. Available at: http://www3.scienceblog.com/community/older/archives/M/2/fda1168.htm. Accessed: October 2, 2017.